An experimental study on the course of trans-synaptic propagation of neural activity and plasticity in the hippocampus in kainate-induced epilepsy

Brain Research Bulletin

Volumn 55, Issue 3, 2001, Pages 393-400

  Sato, Keiko ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Epileptic status; Hippocampus; Immunohistochemistry; In situ hybridization; Kainic acid; Synapsin I

Indexed keywords

BIOLOGICAL MARKER; KAINIC ACID; MESSENGER RNA; PROTEIN; SYNAPSIN I;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DOSE TIME EFFECT RELATION; HIPPOCAMPUS; KINDLING; MALE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; TEMPORAL LOBE EPILEPSY;

ANIMALS; BEHAVIOR, ANIMAL; EPILEPSY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAINIC ACID; MALE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYNAPSES; SYNAPSINS;

EID: 0034899313     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00519-6     Document Type: Article

References (46)

1. Postscript: What terminology is appropriate for tissue pathology? How does it predict outcome?
2. Synaptic reorganization by mossy fibers in human epileptic fascia dentata
3. Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy
4. Molecular neuropathology of human mesial temporal lobe epilepsy
5. Glutamate, GABA and epilepsy
6. The neuropathology of temporal lobe epilepsy
7. Cellular mechanisms of epilepsy: A status report
8. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
9. Distinct roles of synapsin I and synapsin II during neuronal development
10. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus
11. +-evoked release of L-glutamate in entorhinal kindled rats
12. A permanent change in brain function resulting from daily electrical stimulation
13. Synaptic vesicle phosphoproteins and regulation of synaptic function
14. Synapsin I and syntaxin 1B: Key elements in the control of neurotransmitter release are regulated by neuronal activation and long-term potentiation in vivo
15. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system
16. Increase in synaptic vesicle proteins accompanies long-term potentiation in the dentate gyrus
17. Transient increase of synapsin-I immunoreactivity in the mossy fiber layer of the hippocampus after transient forebrain ischemia in mongolian gerbil
18. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus
19. In contrast to kindled seizures, the frequency of spontaneous epilepsy in the limbic status model correlates with greater aberrant fascia dentata excitatory and inhibitory axon sprouting, and increased staining for N-methyl-D-aspartate, AMPA and GABA(A) receptors
20. Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy
21. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
22. The role of glutamate in epilepsy and other CNS disorders
23. Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus
24. Contribution of kindling to clinical epileptology
25. Time-dependent changes in rat hippocampal synapsin I mRNA expression during long-term potentiation
26. Increases in mRNA levels for synapsin I but not synapsin II in the hippocampus of the rat kindling model of epilepsy
27. Synapsin I regulates glutamate release from rat brain synaptosomes
28. Distinct pools of synaptic vesicles in neurotransmitter release
29. Regional increases in brain-derived neurotrophic factor mRNAs during amygdaloid kindling, but not in acidic and basic fibroblast growth factor mRNAs
30. Increased synapsin I. Immunoreactivity during long-term potentiation in rat hippocampus
31. Kindling: Basic mechanisms and clinical validity
32. Behavioral and immunohistochemical study on the development of perirhinal cortical kindling: A comparison with other types of limbic kindling
33. Somatostatin, neuropeptide Y, neurokinin B and cholecytokinin immunoreactivity in two chronic models of temporal lobe epilepsy
34. Neuropeptides-immunoreactivity and their mRNA expression in kindling: Functional implications for limbic epileptogenesis
35. Chronic epileptogenecity following focal status epilepticus
36. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy
37. Status epilepticus-induced neuronal injury and network reorganization
38. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat
39. Increment of synapsin I immunoreactivity in the rat hippocampus of the rat kindling model of epilepsy
40. Synaptic reorganization in the hippocampus induced by abnormal functional activity
41. Mossy fiber synaptic reorganization in the epileptic human temporal lobe
42. Experimental complex partial seizures induced by a microinjection of kainic acid into limbic structures
43. Neuropeptide Y: Merging evidence for a functional role in seizure modulation
44. Increase in synapsin I phosphorylation implicates a presynaptic component in septal kindling
45. Changes in the expression of synapsin I and II messenger RNA during postnatal rat brain development